Guangyi Yang

Prof. Guangyi Yang

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
YYYang Yang
Yang Yang
QCQinhua Chen
Qinhua Chen
QWQizhang Wang
Qizhang Wang
SZShuya Zhang
Shuya Zhang
JLJingjian Liu
Jingjian Liu
GYGuangyi Yang
Guangyi Yang

27 February 2023 in Molecules
Verified
Journal Article
Open access
PDF file
MZMoli Zhang
Moli Zhang
YYYang Yang
Yang Yang
LXLingyi Xin
Lingyi Xin
HZHua Zhang
Hua Zhang
LWLun Wu
Lun Wu
GYGuangyi Yang
Guangyi Yang
Recently, miRNAs have become a promising biomarker for disease diagnostics. miRNA-145 is closely related to strokes. The accuracy determination of miRNA-145 (miR-145) in stroke patients still remains challenging due to its heterogeneity and low abundance, as well as the complexity of the blood matrix. In this work, we developed a novel electrochemical miRNA-145 biosensor via subtly coupling the cascade strand displacement reaction (CSDR), exonuclease III (Exo III), and magnetic nanoparticles (MNPs). The developed electrochemical biosensor can quantitatively detect miRNA-145 ranging from 1 × 102 to 1 × 106 aM with a detection limit as low down as 100 aM. This biosensor also exhibits excellent specificity to distinguish similar miRNA sequences even with single-base differences. It has been successfully applied to distinguish healthy people from stroke patients. The results of this biosensor are consistent with the results of the reverse transcription quantitative polymerase chain reaction (RT-qPCR). The proposed electrochemical biosensor has great potential applications for biomedical research on and clinical diagnosis of strokes.

23 October 2025 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
SCShuangli Chen
Shuangli Chen
CDChengshuo Deng
Chengshuo Deng
YLYixuan Liu
Yixuan Liu
XHXuanmei Huang
Xuanmei Huang
XCXulong Chen
Xulong Chen
HLHelu Liu
Helu Liu
The emergence of multidrug-resistant bacteria poses a severe challenge to infection treatment, creating an urgent need for novel antimicrobial agents. Monomers derived from natural products exhibit multi-mechanism antibacterial properties with low resistance development potential. However, evaluation of these monomers is frequently hampered by color interference in traditional turbidimetric methods. This study developed a high-throughput fully automated bacterial growth curve monitor (HTFA-BGM) to provide a new tool for screening and assessing antimicrobial monomers. The HTFA-BGM was designed and developed based on the principle of scattering nephelometry. Its performance in determining the minimum inhibitory concentration (MIC) was compared with the microdilution and the tube dilution methods. After establishing the instrument's MIC determination criterion, it was used to evaluate and screen the antibacterial effects of Traditional Chinese Medicine (TCM) monomers. The HTFA-BGM could screen MICs of 40 monomers against one strain or one monomer against 40 strains simultaneously, unaffected by compound color. When a threshold of ≤ 10% for the ratio of sample turbidity change to bacterial suspension turbidity change was used as the MIC criterion, there was no significant difference between the HTFA-BGM method and the microdilution or tube dilution methods. The HTFA-BGM was used to evaluate 15 monomers (including polyphenolic, quinonoid, and other types of compounds), and the MIC of rhein against 90 strains of Methicillin-Resistant Staphylococcus aureus (MRSA) was 8–64 μg/mL. The synergistic rates of rhein combined with penicillin, cefoxitin, cefazolin or oxacillin against MRSA in vitro were 30% (27/90), 63% (57/90), 57% (51/90), and 58% (52/90), respectively, whereas the additive rates were 70% (63/90), 37% (33/90), 43% (39/90), and 42% (38/90), respectively. The MIC of oleanolic acid against 13 isolates of vancomycin-resistant Enterococcus (VRE) was 16–32 μg/mL. When combined with vancomycin, vancomycin MIC decreased from 256–1024 to 1 μg/mL. The HTFA-BGM enables automatic, real-time, and dynamic monitoring of bacterial growth curves. Compared with the microdilution method, which determines the MIC on the basis of endpoint turbidity, this instrument not only has improved efficiency but also yields more objective and accurate results. This method specifically resolves the interference caused by the intrinsic color of colored TCM monomers such as rhein during their determination tests. Therefore, it is better suited for evaluating and screening antibacterial TCM monomers. The HTFA-BGM demonstrates excellent practical applicability and warrants broad promotion and application.

10 July 2026 in Journal of Separation Science
Verified
Journal Article
Closed access
PDF file
LXLingyi Xin
Lingyi Xin
XWXuemei Wei
Xuemei Wei
RLRenyan Liu
Renyan Liu
YLYun Li
Yun Li
YYYang Yang
Yang Yang
GYGuangyi Yang
Guangyi Yang

17 February 2026 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
QZQiulong Zhao
Qiulong Zhao
YCYuanyuan Cao
Yuanyuan Cao
ZZZhenyi Zhang
Zhenyi Zhang
YYYang Yang
Yang Yang
LWLi Wang
Li Wang
GYGuangyi Yang
Guangyi Yang